DT Investment Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Hold
644
0.02% 139
2026
Q1
$189K Hold
644
0.02% 149
2025
Q4
$226K Hold
644
0.02% 140
2025
Q3
$208K Hold
644
0.02% 141
2025
Q2
$250K Hold
644
0.02% 131
2025
Q1
$280K Hold
644
0.03% 128
2024
Q4
$238K Hold
644
0.02% 134
2024
Q3
$335K Buy
644
+30
+5% +$16K 0.03% 123
2024
Q2
$333K Hold
614
0.03% 116
2024
Q1
$318K Hold
614
0.03% 110
2023
Q4
$302K Buy
614
+183
+42% +$84.6K 0.03% 114
2023
Q3
$188K Hold
431
0.02% 128
2023
Q2
$202K Hold
431
0.02% 130
2023
Q1
$204K Hold
431
0.02% 125
2022
Q4
$221K Hold
431
0.03% 120
2022
Q3
$196K Sell
431
-431
-50% -$206K 0.03% 118
2022
Q2
$416K Hold
862
0.06% 110
2022
Q1
$423K Buy
862
+328
+61% +$150K 0.05% 121
2021
Q4
$248K Sell
534
-122
-19% -$51.3K 0.03% 120
2021
Q3
$245K Buy
+656
New +$249K 0.03% 136

Other funds holding ELV

DT Investment Partners's ELV Position: Q2 2026 in Review

DT Investment Partners held its Elevance Health (ELV) position steady in Q2 2026 at 644 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #139.

DT Investment Partners first reported a position in ELV in Q3 2021 and has held it in 20 quarters since. The position peaked at $423K in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DT Investment Partners held 644 shares of Elevance Health worth $249K as of Q2 2026.
  • DT Investment Partners left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.02% of DT Investment Partners's portfolio in Q2 2026, its #139 holding.
  • DT Investment Partners first reported a position in Elevance Health in Q3 2021 and has held it in 20 quarters since.
  • DT Investment Partners's Elevance Health position peaked at $423K in Q1 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.